Nanox is an R&D oriented healthcare company dedicated to developing specialized formulations for oncology, hematology and AIDS indication based on nanotech drug delivery technologies.
Our mission is to enhance lives through innovative and cost-effective pharmaceutical solutions. We are dedicated to researching, developing, and delivering high-quality innovative treatments that address urgent health needs globally. With a focus on collaboration, ethics, and sustainability, we strive to improve patient quality of life and advance medical science, prioritizing safety and well-being in everything we do.
Liposomes are cell-like structures composed by a durable lipid bilayer capable of hosting drugs of diverse nature whether inside or intercalated in the surface. This structural arrangement allows for improvement in both biodistribution and stability.
Pegylation
This technology is used to increase product´s half-life, reduce immune response and improve formulation´s stability towards aggregation.
Microspheres
Biodegradable polymer microspheres are used when fine control of the drug release profile is needed. This technology can achieve steady, continuous levels of the therapeutic agent for a long period of time avoiding both multiple applications as well as unwanted peak levels of the drug.
Nanomicelles
Nanox´s proprietary GM1 nanomicelle technology allows the encapsulation of drugs with very different characteristics with high efficiency by means of simple, robust self-assembly & self-load process. GM1 encapsulation has proven efficient not only in modifying the drug´s biodistribution profile but also protecting the cargo from degradation
Microfluids
By studying the behavior of fluids in the micro scale and by means of thorough control of the process variables, precise adjustments on droplet size can be achieved; enabling manufacturing of homogeneous microspheres with a perfectly tuned release profile
Our products
We are dedicated to advancing healthcare through a diverse portfolio of innovative pharmaceutical products. Our commitment to research and development drives us to create high-quality treatments that meet the evolving needs of patients around the world.